Merck & Co., Inc.

BVL:MRK Stock Report

Market Cap: US$253.1b

Merck & Co., Inc. Company Information

Merck & Co., Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Merck & Co., Inc.
  • Ticker: MRK
  • Exchange: BVL
  • Founded: 1891
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$253.115b
  • Shares Outstanding: 2.53b
  • Website: https://www.merck.com

Number of Employees

Location

  • Merck & Co., Inc.
  • 126 East Lincoln Avenue
  • Rahway
  • New Jersey
  • 07065
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MRKNYSE (New York Stock Exchange)YesCommon StockUSUSDJan 1968
MRKBVL (Bolsa de Valores de Lima)YesCommon StockPEUSDJan 1968
MRK *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNJan 1968
6MKDB (Deutsche Boerse AG)YesCommon StockDEEURJan 1968
010683053BRSE (Berne Stock Exchange)YesCommon StockCHCHFJan 1968
0QAHLSE (London Stock Exchange)YesCommon StockGBUSDJan 1968
6MKXTRA (XETRA Trading Platform)YesCommon StockDEEURJan 1968
MRKSNSE (Santiago Stock Exchange)YesCommon StockCLUSDJan 1968
4MRKXETLX (Eurotlx)YesCommon StockITEURJan 1968
MRKWBAG (Wiener Boerse AG)YesCommon StockATEURJan 1968
6MKBUL (Bulgaria Stock Exchange)YesCommon StockBGEURJan 1968
MRKCLSNSE (Santiago Stock Exchange)YesCommon StockCLCLPJan 1968
6MKDBATS-CHIXE (BATS 'Chi-X Europe')YesCommon StockGBEURJan 1968
MRKBASE (Buenos Aires Stock Exchange)CEDEAR EAC 5 RE 1 (USD)ARARSMar 2000
MRKDBASE (Buenos Aires Stock Exchange)CEDEAR EAC 5 RE 1 (USD)ARUSDMar 2000
MRCK34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 8 REP 1 COMBRBRLDec 2011

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/12/18 08:41
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 08:41
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Merck & Co., Inc. is covered by 61 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Fabrizio SpagnaAxia Financial Research
Ishan MajumdarBaptista Research